Advanced search

Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative I-131-lipiodol therapy.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
BRANS, B, Bieke Lambert, E DE BEULE, F DE WINTER, Simon Van Belle, Hans Van Vlierberghe, Bernard de Hemptinne, and Rudi Dierckx. 2002. “Quality of Life Assessment in Radionuclide Therapy: a Feasibility Study of the EORTC QLQ-C30 Questionnaire in Palliative I-131-lipiodol Therapy.” European Journal of Nuclear Medicine and Molecular Imaging 29 (10: 1374–1379.
APA
BRANS, B., Lambert, B., DE BEULE, E., DE WINTER, F., Van Belle, S., Van Vlierberghe, H., de Hemptinne, B., et al. (2002). Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative I-131-lipiodol therapy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 29 (10, 1374–1379.
Vancouver
1.
BRANS B, Lambert B, DE BEULE E, DE WINTER F, Van Belle S, Van Vlierberghe H, et al. Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative I-131-lipiodol therapy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2002;29 (10:1374–9.
MLA
BRANS, B, Bieke Lambert, E DE BEULE, et al. “Quality of Life Assessment in Radionuclide Therapy: a Feasibility Study of the EORTC QLQ-C30 Questionnaire in Palliative I-131-lipiodol Therapy.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 29 (10 (2002): 1374–1379. Print.
@article{167177,
  author       = {BRANS, B and Lambert, Bieke and DE BEULE, E and DE WINTER, F and Van Belle, Simon and Van Vlierberghe, Hans and de Hemptinne, Bernard and Dierckx, Rudi},
  issn         = {1619-7070},
  journal      = {EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING},
  language     = {eng},
  pages        = {1374--1379},
  title        = {Quality of life assessment in radionuclide therapy: a feasibility study of the EORTC QLQ-C30 questionnaire in palliative I-131-lipiodol therapy.},
  volume       = {29 (10},
  year         = {2002},
}

Web of Science
Times cited: